Electra Therapeutics
SIRP-targeted antibody therapies for immune disease and cancer
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies that target signal regulatory proteins (SIRP) for immunological diseases and cancer. Lead programs include ELA026. The company completed an upsized U.S. IPO in September 2026 (Nasdaq: ETRA).
- Website
- electra-therapeutics.com
- Stage
- public
- Location
- South San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed